Als, Thomas D. http://orcid.org/0000-0002-2963-1928
Kurki, Mitja I.
Grove, Jakob http://orcid.org/0000-0003-2284-5744
Voloudakis, Georgios http://orcid.org/0000-0002-5729-632X
Therrien, Karen http://orcid.org/0000-0003-3351-7260
Tasanko, Elisa
Nielsen, Trine Tollerup
Naamanka, Joonas http://orcid.org/0000-0003-3092-7416
Veerapen, Kumar
Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Bendl, Jaroslav http://orcid.org/0000-0001-9989-2720
Bybjerg-Grauholm, Jonas
Zeng, Biao
Demontis, Ditte http://orcid.org/0000-0001-9124-2766
Rosengren, Anders http://orcid.org/0000-0002-6682-1288
Athanasiadis, Georgios http://orcid.org/0000-0002-2927-4035
Bækved-Hansen, Marie
Qvist, Per http://orcid.org/0000-0002-0750-0089
Bragi Walters, G. http://orcid.org/0000-0002-5415-6487
Thorgeirsson, Thorgeir http://orcid.org/0000-0002-5149-7040
Stefánsson, Hreinn
Musliner, Katherine L.
Rajagopal, Veera M. http://orcid.org/0000-0002-5236-168X
Farajzadeh, Leila
Thirstrup, Janne
Vilhjálmsson, Bjarni J. http://orcid.org/0000-0003-2277-9249
McGrath, John J.
Mattheisen, Manuel
Meier, Sandra
Agerbo, Esben
Stefánsson, Kári
Nordentoft, Merete
Werge, Thomas http://orcid.org/0000-0003-1829-0766
Hougaard, David M. http://orcid.org/0000-0001-5928-3517
Mortensen, Preben B.
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Hovatta, Iiris http://orcid.org/0000-0002-5990-7892
Roussos, Panos
Daly, Mark J.
Mors, Ole
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Børglum, Anders D. http://orcid.org/0000-0001-8627-7219
Article History
Received: 30 June 2022
Accepted: 17 April 2023
First Online: 18 July 2023
Competing interests
: B.J.V. is a member of the advisory board for Allelica. D.D. has received a speaker fee from Takeda. B.W., T.T., H.S. and K.S. are employed at deCODE/Amgen. M.J.D. is a founder of Maze Therapeutics and is on the Scientific Advisory Board of RBNC Therapeutics. The other authors declare no competing interests.